$1.09
1.83%
Downside
Day's Volatility :2.73%
Upside
0.91%
76.15%
Downside
52 Weeks Volatility :97.11%
Upside
87.89%
Period | Pavmed Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -6.03% | 5.1% | 0.0% |
6 Months | -61.48% | 4.9% | 0.0% |
1 Year | -85.41% | 16.6% | 0.0% |
3 Years | -99.11% | 13.2% | -22.3% |
Market Capitalization | 10.8M |
Book Value | - $7.7 |
Earnings Per Share (EPS) | -8.08 |
PEG Ratio | 0.0 |
Wall Street Target Price | 10.0 |
Profit Margin | 0.0% |
Operating Margin TTM | -1397.75% |
Return On Assets TTM | -80.07% |
Return On Equity TTM | -1358.06% |
Revenue TTM | 3.8M |
Revenue Per Share TTM | 0.46 |
Quarterly Revenue Growth YOY | 489.79999999999995% |
Gross Profit TTM | -3.2M |
EBITDA | -57.3M |
Diluted Eps TTM | -8.08 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -5.91 |
EPS Estimate Next Year | -2.56 |
EPS Estimate Current Quarter | -1.45 |
EPS Estimate Next Quarter | -1.29 |
What analysts predicted
Upside of 817.43%
Sell
Neutral
Buy
Pavmed Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Pavmed Inc | 40.65% | -61.48% | -85.41% | -99.11% | -92.62% |
![]() Stryker Corporation | 12.3% | 0.36% | 24.19% | 28.8% | 65.26% |
![]() Boston Scientific Corp. | 10.6% | 20.32% | 51.42% | 80.93% | 95.5% |
![]() Edwards Lifesciences Corp. | 9.4% | -28.78% | -12.2% | -45.23% | -7.73% |
![]() Abbott Laboratories | 3.57% | -5.84% | 13.1% | -11.32% | 35.19% |
![]() Medtronic Plc | 10.85% | 5.57% | 12.46% | -33.2% | -16.71% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Pavmed Inc | NA | NA | 0.0 | -5.91 | -13.58 | -0.8 | NA | -7.7 |
![]() Stryker Corporation | 39.84 | 39.84 | 2.64 | 12.0 | 0.19 | 0.07 | 0.01 | 51.86 |
![]() Boston Scientific Corp. | 66.34 | 66.34 | 2.01 | 2.41 | 0.09 | 0.05 | NA | 13.85 |
![]() Edwards Lifesciences Corp. | 26.3 | 26.3 | 3.2 | 2.69 | 0.22 | 0.12 | NA | 12.35 |
![]() Abbott Laboratories | 35.92 | 35.92 | 4.16 | 4.66 | 0.14 | 0.06 | 0.02 | 22.6 |
![]() Medtronic Plc | 30.16 | 30.16 | 1.66 | 5.2 | 0.08 | 0.04 | 0.03 | 37.39 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Pavmed Inc | Buy | $10.8M | -92.62% | NA | 0.0% |
![]() Stryker Corporation | Buy | $136.8B | 65.26% | 39.84 | 16.12% |
![]() Boston Scientific Corp. | Buy | $120.2B | 95.5% | 66.34 | 12.0% |
![]() Edwards Lifesciences Corp. | Buy | $40.2B | -7.73% | 26.3 | 23.74% |
![]() Abbott Laboratories | Buy | $198.1B | 35.19% | 35.92 | 13.65% |
![]() Medtronic Plc | Buy | $115.3B | -16.71% | 30.16 | 12.06% |
Insights on Pavmed Inc
Revenue is down for the last 3 quarters, 1.04M → 979.0K (in $), with an average decrease of 3.4% per quarter
Netprofit is up for the last 2 quarters, -15.21M → -10.82M (in $), with an average increase of 40.5% per quarter
In the last 1 year, Boston Scientific Corp. has given 51.4% return, outperforming this stock by 136.8%
In the last 3 years, Boston Scientific Corp. has given 80.9% return, outperforming this stock by 180.0%
First Manhattan Co. LLC
Vanguard Group Inc
BlackRock Inc
Geode Capital Management, LLC
TWO SIGMA SECURITIES, LLC
State Street Corporation
pavmed is a groundbreaking medical device company bringing innovative medical technologies from concept to commercialization with unprecedented speed and efficiency. led by three accomplished medical device entrepreneurs and organized to conceive, develop and commercialize a diversified pipeline of innovative products we believe address unmet clinical needs, our goal is to enhance and accelerate value creation by employing a business model focused on capital and time efficiency.
Organization | Pavmed Inc |
Employees | 107 |
CEO | Dr. Lishan Aklog M.D. |
Industry | Health Technology |
A Spac I Acquisition Corp
$1.09
-6.03%
Keyarch Acquisition Corp
$1.09
-6.03%
Connexa Sports Technologies Inc
$1.09
-6.03%
Us Value Etf
$1.09
-6.03%
First Wave Biopharma Inc
$1.09
-6.03%
Global X Msci Next Emerging
$1.09
-6.03%
Fat Projects Acquisition Corp
$1.09
-6.03%
Capital Link Global Fintech
$1.09
-6.03%
Applied Uv Inc
$1.09
-6.03%